A new timeline: Strategies to accelerate diagnosis and improve outcomes
After an abnormal cancer screening, it takes an average of 156 days to reach diagnosis — a delay that increases costs, worsens outcomes and exposes gaps in care.
This report outlines a new model: shifting clinical intervention earlier in the cancer journey, where outcomes improve and costs are still controllable.
Plans are now closing gaps by clinically managing screening, diagnosis and survivorship care.
What you’ll learn:
This report outlines a new model: shifting clinical intervention earlier in the cancer journey, where outcomes improve and costs are still controllable.
Plans are now closing gaps by clinically managing screening, diagnosis and survivorship care.
What you’ll learn:
- How earlier-stage detection can reduce costs by $60K+ per patient and improve survival rates
- Why 52% of cancer-related ED visits are avoidable with better clinical oversight
- Strategies to identify high-risk members and ensure timely follow-up
Please fill out the form to download the whitepaper.